SHIRUDE, Pravin Sudhakar,BALIGAR, Vishweshwaraiah,SESHADRI, Balaji,CHATTOPADHYAY, Amit Kumar,WURTZ,, Nicholas R.,KICK, Ellen K.
申请号：
AU2019232704
公开号：
AU2019232704A1
申请日:
2019.03.04
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The disclosure relates to compounds of Formula (II), which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists. The disclosure also provides compositions and methods of using the compounds, for example, for the treatment of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.
